Global Microfluidic Market, by Material Type (Silicon-Based Microfluidic, Glass-Based Microfluidic, Polymer-Based Microfluidic, and Others), by Application (In Vitro Diagnostic Devices, Drug Delivery Devices and Monitoring Devices), and by Region - Trends and Forecast till 2025

Microfluidic Market 

Microfluidic devices enables the precise processing of micro liter (~0.01-10 µl) samples and allows to perform significant biological or chemical processing such as sampling, pre-processing and measurement involved in an assay within a single chip. Microfluidics aids in handling and examining very small fluid volumes, around micro- (10-6) to atto- (10-18) liter volumes of fluid, which provides several analytical and economic advantages over the conventional assays. Microfluidic devices typically requires 10x times less sample volume, thereby allowing less sample and reagent consumption. Microfluidic devices transfers such small amount of fluid volume through microfluidic channels, which provides higher surface area to volume ratio, which further enhance the heat transfer. Increasing advancements in microfluidics such as lab-on-a-chip device for DNA amplification, purification, separation and sequencing, and single cell gene-expression profiling is expected to aid in growth of the market. Microfluidic provides enhanced analytical sensitivity, enhanced temperature control, faster reaction time, cost efficiency and allows integration of lab routines in a single device.

The global microfluidic market was valued at US$ 2.8 billion in 2016 and is expected to witness a robust CAGR of 19.4% over the forecast period (2017–2025).

Figure 1. Global Microfluidic Market, by Region, 2016 (US$ Mn)

microfluidic market

Source: Coherent Market Insights (2017)

Rising demand for point-of-care testing to augment microfluidic market growth

Point-of-care testing (POC Testing) is medical diagnostic testing performed primarily outside medical care facilities and in close proximity that is at the time and place of patient care. Point-of-care testing is relatively expensive than regular lab testing; however, it offers appropriate and immediate results for further clinical management. Microfluidic technology primarily offers three advantages to POC diagnostic: smaller sample volume, lower test costs, and faster detection time. Point-of-care testing enables miniaturization and integration of complex functions facilitating their usage in limited resources.

Continuous innovation strategy adopted by manufacturers is expected to aid in accelerating growth of the microfluidic market       

Adoption of microfluidics as a key technology in medical science and biosensing is increasing significantly in the recent past. Manufacturers are focusing on continuous innovation in microfluidic technology such as laboratory-on-a-chip, point-of-care testing, microfluidic enabled drug delivery systems, and microfluidic gradient generators to enhance their product portfolios. Introduction of thermoplastic as a new material for microfluidic device fabrication instead of conventional PDMS polymer, adoption of novel microfluidic flow rate detection method, and advancement in nanoparticle separation using microfluidic devices is further expected to boost the microfluidic market in the near future. Microfluidic techniques are being extensively used to separate micro sized particles such as blood cells, parasites, spores, tumor cells, and bacteria due to its advantages such as low sample volume, low cost, and miniature sample handing with precise control. However, to separate submicron particle, nanofluidics is emerging as a suitable technology for separation.

Some of the major players operating in the microfluidic market are Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, PerkinElmer Inc., Siemens Healthcare GmbH, and Micronit Microfluidic BV

Microfluidic is a science of handling and manipulation of very small fluid volumes to study behavior of fluids through micrometer sized channels and technology, to manufacture microminiaturized devices. Microfluidic deals with very small volume of fluid at the femtoliter (fL) enabling several benefits over conventional laboratory cell culture assay such as lower fabrication costs, reduced reagent consumption, and improved performance. This is owing to the capacity of microfluidics to perform multiple analyses on a single chip. Various sample operations can be executed at same time due to compact size, while shortening the time of experiment.

Market Dynamics

Major factors influencing growth of the microfluidic market is rising demand for point-of-care (POC) testing and advancements in microfluidic technology to reduce cost of sample analysis and enabling higher efficiency. Moreover, increasing demand for home healthcare to address growing prevalence of diabetes is supporting to growth of the microfluidic market. For instance, in 2017 researchers at the Ewha Womens University developed an endocrine system on chip, based on microfluidic perfused 3D cell-culture chip which detect the drugs for the treatment of diabetes by measuring insulin release over time. According to the statistics published by International Diabetes Federation (IDF), the global prevalence of diabetes is around 424.9 million in 2017, which is expected to increase to 628.6 million in 2045. In addition, increasing innovation in microfluidics technology is further expected to bolster growth of the market. Researchers at the Brigham Young University, in April 2017, developed first 3D-print viable microfluidic device which has size less than 100 micrometers and employed to use in molecular biology, proteomics and cell biology diagnostic technologies.

Key features of the study:

  • This report provides in-depth analysis of microfluidic market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global microfluidic market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific Inc., Qiagen N.V., Bio-Rad Laboratories, Inc. , F. Hoffmann-La Roche Ltd, Fluidigm Corporation, Danaher Corporation, PerkinElmer Inc., Siemens Healthcare GmbH, and Micronit Microfluidic BV
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, product innovation, market expansion, and marketing tactics
  • The global microfluidic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the microfluidic market

Detailed Segmentation:

  • Global Microfluidic Market, By Material Type:
    • Silicon-Based Microfluidic
    • Glass-Based Microfluidic
    • Polymer-Based Microfluidic
    • Other Materials- Based (Paper & Ceramics) Microfluidic
  • Global Microfluidic Market, By Application:
    • In Vitro Diagnostic Devices
    • Drug Delivery Devices
    • Monitoring Devices
  • Global Microfluidic Market, By Geography:
    • North America
      • By Material Type:
        • Silicon-Based Microfluidic
        • Glass-Based Microfluidic
        • Polymer-Based Microfluidic
        • Other
      • By Application:
        • In Vitro Diagnostic Devices
        • Drug Delivery Devices
        • Monitoring Devices
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Material Type:
        • Silicon-Based Microfluidic
        • Glass-Based Microfluidic
        • Polymer-Based Microfluidic
        • Other
      • By Application:
        • In Vitro Diagnostic Devices
        • Drug Delivery Devices
        • Monitoring Devices
      • By Country:
        • Brazil
        • Mexico
        • Rest of Latin America
    • Europe
      • By Material Type:
        • Silicon-Based Microfluidic
        • Glass-Based Microfluidic
        • Polymer-Based Microfluidic
        • Other
      • By Application:
        • In Vitro Diagnostic Devices
        • Drug Delivery Devices
        • Monitoring Devices
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Material Type:
        • Silicon-Based Microfluidic
        • Glass-Based Microfluidic
        • Polymer-Based Microfluidic
        • Other
      • By Application:
        • In Vitro Diagnostic Devices
        • Drug Delivery Devices
        • Monitoring Devices
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Material Type:
        • Silicon-Based Microfluidic
        • Glass-Based Microfluidic
        • Polymer-Based Microfluidic
        • Other
      • By Application:
        • In Vitro Diagnostic Devices
        • Drug Delivery Devices
        • Monitoring Devices
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Material Type:
        • Silicon-Based Microfluidic
        • Glass-Based Microfluidic
        • Polymer-Based Microfluidic
        • Other
      • By Application:
        • In Vitro Diagnostic Devices
        • Drug Delivery Devices
        • Monitoring Devices
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Agilent Technologies
    • Thermo Fisher Scientific Inc.
    • Qiagen N.V.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd
    • Fluidigm Corporation
    • Danaher Corporation
    • PerkinElmer Inc.
    • Siemens Healthcare GmbH
    • Micronit Microfluidic BV

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Material Type
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • Impact Analysis
    • Regulatory Scenario
    • Recent Launches
    • Mergers & Acquisitions
    • Product Evolution
    • Future Prospects
    • PEST Analysis
  4. Global Microfluidic Market, By Material Type, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017–2025
      • Segment Trends
    • Silicon-Based Microfluidic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Glass-Based Microfluidic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Polymer-Based Microfluidic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
  5. Global Microfluidic Market, By Application, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017–2025
      • Segment Trends
    • In Vitro Diagnostic Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Drug Delivery Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Monitoring Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
  6. Global Microfluidic Market, By Region, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2025
    • North America
      • Market Size and Forecast, By Material Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Material Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Material Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Material Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Material Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Material Type, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Agilent Technologies
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Qiagen N.V.
        •  Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • F. Hoffmann-La Roche Ltd
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Fluidigm Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • PerkinElmer Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Siemens Healthcare GmbH
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Micronit Microfluidic BV
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 30 market data tables and 35 figures on "Microfluidic Market - Global forecast to 2025”.

 

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.